In this study we show that E6 of human papillomavirus has the ability to deregulate the cell cycle G1/S transition. In rodent immortalized fibroblasts (NIH3T3) serum deprivation or over-expression of the cyclin-dependent kinase inhibitors, p16
Introduction
Clinical, epidemiologic and molecular data have clearly demonstrated that certain human papillomavirus (HPV) types, those so-called high risk, are the etiological agents of cervical cancer (zur Hausen, 2000) . HPV16 is the high risk type most frequently found in pre-malignant and malignant cervical lesions worldwide. Numerous studies on the high risk HPV types have demonstrated that the products of two early genes, E6 and E7, play a key role in the induction of pre-malignant and malignant cervical lesions (Tommasino and Jansen-Du¨rr, 1997). HPV16 E6 and E7 exert their functions by associating with and altering the biological function of several cellular proteins. The best characterized HPV16 E6 activity is its ability to induce degradation of the tumor suppressor protein p53 via the ubiquitin pathway (reviewed in Thomas et al., 1999) . Since the function of p53 is to safeguard the integrity of the genome, cells expressing HPV16 E6 show chromosomal instability, which greatly increases the probability that HPV-infected cells will evolve towards malignancy. In addition, HPV16 E6 targets other cellular pathways that are p53-independent (Thomas et al., 1999) .
The other viral oncoprotein, E7, impacts on several cellular pathways in the cytoplasm and the nucleus (reviewed in Zwerschke and Jansen-Durr, 2000) . The E7 proteins from the high risk HPV types are strong activators of the cell cycle. They promote G1/S transition even in the presence of negative cell cycle regulators or in the absence of mitogenic signals (Tommasino and Jansen-Du¨rr, 1997) . This E7 activity is essential to guarantee viral DNA replication and is in part explained by inactivation of the tumor suppressor retinoblastoma (pRb). In quiescent cells, the hypophosphorylated form of pRb negatively regulates, via direct association, the activity of several transcription factors, including members of the E2F family (Morris and Dyson, 2001) . When quiescent cells are exposed to mitogenic signals, cyclin-dependent kinases (CDKs) are activated, which in turn phosphorylate pRb in G1 phase, causing release of E2F (Sherr and Roberts, 1999) . Finally, the free and active E2F promotes the transcription of a group of genes that encode proteins such as cyclin E and cyclin A, essential for S phase entry.
Several cellular mechanisms regulate the activity of CDKs (Sherr and Roberts, 1999) . For instance, small proteins associate with active cyclin/CDK complexes and strongly inhibit their kinase activity. p16
INK4a is a CDK inhibitor, which acts at G1 phase blocking the CDK4 and CDK6 activity (Sherr and Roberts, 1999) . Its ectopic expression leads to an accumulation of hypophosphorylated pRb, sequestration of E2F and consequent G1 arrest (Lukas et al., 1995) . The neutralization of pRb functions by HPV16 E7 results in a constitutive activation of E2Fs and makes cell cycle progression independent of mitogenic signals and CDK activation (Tommasino and Jansen-Du¨rr, 1997) . HPV16 E7 inactivates pRb by direct association and promotes its deregulation via the proteasome pathway (Boyer et al., 1996; Dyson et al., 1989; Jones and Munger, 1997) . Studies on other HPV types have shown that this E7 mechanism in targeting pRb is not conserved in the E7 protein of all HPV types (AlunniFabbroni et al., 2000; Caldeira et al., 2000; Ciccolini et al., 1994; Munger et al., 1989; Schmitt et al., 1994) . Indeed, E7s from the non-oncogenic HPV types have a reduced efficiency in neutralizing pRb and in altering cell cycle regulation (Gage et al., 1990; Martin et al., 1998) . However, in spite of the lack of this E7 function, these HPV types are still fully competent in deregulating the cell cycle and inducing proliferation in vivo. This fact suggests that other viral proteins contribute to the stimulation of S phase entry.
In this study, we have investigated whether the HPV16 E6 protein can have a direct effect on deregulation of G1/S transition in immortalized rodent fibroblasts (NIH3T3), which has been widely used to assess the impact of oncogenes upon cell cycle regulation and transformation. We show that HPV16 E6 is able to drive into S phase in the absence of mitogenic signals or in presence of high levels of cell cycle inhibitors, p16
INK4a or p27 KIP1 . This E6 activity is also conserved in the non-oncogenic HPV type 1. Finally, our findings indicate that E6 acts up-stream of pRb to alleviate the G1 arrest imposed by antiproliferative signals.
Results

HPV16 E6 alleviates the G1 arrest imposed by serum deprivation
To establish whether HPV16 E6 alters the regulation of the G1/S transition, we determined the ability of the viral protein to sustain proliferation of immortalized 3 CDK2 is highly active in serum deprived cells expressing HPV16 E6. NIH3T3 cells infected with empty or HPV16 E6 expressing retrovirus were cultured in DMEM containing 0.5% calf serum. After 48 h, protein extracts were prepared as described in Materials and methods and cyclin/CDK2 complexes were immunoprecipitated using a specific anti CDK2 antibody. The kinase activity associated with the immuno-pellet was determined using as substrate histone H1. Autoradiography of the CDK reaction is shown in the left panel. The intensity of the bands was determined by Phosphorimager scanning (ImageQuant software, Molecular Dynamics). The histone H1-kinase activity in E6-expressing cells was normalized to the activity in control cells (value=1) rodent fibroblasts (NIH3T3) in the absence of mitogenic factors. HPV16 E6 gene expression was achieved using recombinant retroviruses as described in Materials and methods. The expression of the E6 gene was confirmed by RT -PCR (data not shown). Cells infected with empty or with HPV16 E6 retrovirus were cultured for 48 h in medium containing 0.5% calf serum (CS) and the cell cycle profile was determined by FACS. As shown in Figure 1 , an approximately twofold higher S phase cell population was detected in NIH3T3 expressing HPV16 E6 than cells infected with empty retrovirus (n=5, P=0.0001). S phase entry is dependent on the transcriptional activation of several genes, which encode for positive cell cycle regulators, such as cyclins E and A. Therefore, as additional proof for the HPV16 E6-mediated S phase stimulation, we determined whether cyclins E and A promoters are activated in serum deprived cells in the absence or presence of HPV16 E6. We observed that both cyclin promoters are 4 -5-fold more active in HPV16 E6 expressing cells than in the control (Figure 2a ,b) (cyclin E promoter activation, n=4, P=0.0004; cyclin A promoter activation, n=4, P40.0001). Accordingly, endogenous levels of cyclin A mRNA were upregulated in serum deprived cells in the presence of HPV16 E6, but not in mock cells (data not shown). Cyclins E and A exert their positive role in cell cycle progression by interacting with and activating the cyclin-dependent kinase 2 (CDK2). Therefore, the increase of cyclins E and A levels in E6 expressing cells should correspond to higher levels of CDK2 activity. Indeed, we observed that the kinase activity associated with CDK2 was stimulated approximately 3 -4-fold in serum deprived HPV16 E6 expressing cells in comparison to cells infected with empty retrovirus (Figure 3 ). Together, these data show that HPV16 E6 is able to alleviate the G1 arrest imposed by serum deprivation.
HPV16 E6 overcomes the activity of the CDK inhibitors, p16
INK4a and p27
KIP1
CDK inhibitors are key regulators of cell cycle and its expression leads to cell cycle arrest. We have analysed INK4a retrovirus, they were diluted 200 times and allowed to grow for 10 -15 days as described in Vlach et al. (1996) . After this period, cells were washed in PBS and colonies fixed in 20% methanol and stained with crystal violet. (d) For the quantification of size colony a direct correlation between intensity of the stained colony versus number of cells per colony was estimated by counting several randomly selected colonies. Based on this correlation we determined the number and sizes of all colonies in the plates the ability of HPV16 E6 to drive rodent fibroblasts into S phase in the presence of high levels of the CDK inhibitor p16
INK4a . To co-express HPV16 E6 and p16
INK4a genes we performed consecutive infections with recombinant retroviruses as previously described (Alevizopoulos et al., 1997; Giarre`et al., 2001; Serrano et al., 1997; Vlach et al., 1996) . It has been reported that HPV16 E7 efficiently overcomes the p16
INK4a -imposed G1 cell cycle arrest (Giarre`et al., 2001; Mann and Jones, 1996) . Therefore HPV16 E7 expressing cells were used as the positive control. p16
INK4a immunoblot analysis showed that the CDK inhibitor is efficiently synthesized (Figure 4a ). Flow cytometry analysis revealed that the levels of S phase cells is higher in HPV16E6/p16
INK4a cells than in cells expressing the CDK inhibitor alone (Figure 4b (n=4,  P=0.0063 ). E7 appears to be more efficient than E6 in circumventing cell cycle arrest (Figure 4b ). This HPV16 E6 activity was further confirmed by a colony formation assay. In agreement with the previous results, we observed that cells expressing HPV16 E6 and p16
INK4a form bigger colonies than cells expressing p16
INK4a alone (Figure 4c,d ). We next asked whether E6 is able to overcome cell cycle arrest induced by another CDK inhibitor p27 KIP1 . This protein prevents S phase entry by inhibiting the kinase activity of cyclin E/CDK2 complex in late G1 phase (reviewed in Sherr and Roberts, 1999) . After determination of the expression of p27 KIP1 protein levels (Figure 5a ), we analysed the proliferative state in each culture. HPV16 E6 is able to alleviate the G1 arrest imposed by ectopic levels of p27 KIP1 as shown by FACS analysis ( Figure  5b ) (n=4, P=0.0029) and colony formation assay (Figures 5c,d ). As observed in p16
INK4a expressing cells, HPV16 E6 induce S phase progression in presence of p27 KIP1 but with less efficiency than E7.
E6 protein from the benign HPV type 1 alleviates the G1 arrest imposed by antiproliferative signals
To determine whether the deregulation of G1/S transition is an exclusive property of E6 proteins of oncogenic HPV types, we have analysed the activity of HPV1 E6. HPV1 is a non-oncogenic cutaneous type and has been found to be associated with benign skin lesions. Figure 6a shows that HPV1 E6 is capable of alleviating the G1 arrest imposed by serum starvation (n=4, P=0.0087). Similarly, HPV1 E6 stimulates G1/S progression in cells over-expressing p16 INK4a (n=2, P=0.067 (Figure 6b -d) or p27 KIP1 (n=3, P=0.07 (Figure 6e -g ), although its activity appears to be slightly lower than HPV16 E6. In summary, the data presented above indicate that this novel biological activity of E6 is present in malignant and nonmalignant HPV types.
HPV16 E6 does not overcome the G1 arrest induced by a DCDK-pRb mutant
In a physiological situation the G1/S progression is dependent on phosphorylation of pRb and consequent activation of E2F (Sherr and Roberts, 1999), which in turn promotes the transcription of cyclin E and cyclin A. The ability of HPV16 E6 to alleviate the G1 arrest imposed by antiproliferative signals can be explained by two alternative mechanisms. E6 might impact the pRb pathway, inducing the inactivation of the tumor suppressor, e.g. by phosphorylation. As an alternative possibility, the viral protein might act downstream figure. After double retroviral infection, cells were treated as described in Materials and methods. The data are the mean of three independent experiments. (f) Colony formation assay was performed as described in the legend of Figure 4 . (g) The number and size of colonies were determined as described in the legend of Figure 4 from pRb, activating, for instance, the cyclins E and A transcription by and E2F-independent mechanism. To clarify the E6 mechanism we have used a pRb mutant (DCDK-pRb) in which all CDK phosphorylation sites have been substituted with alanine residues (Lukas et al., 1997) . Overexpression of the DCDK-pRb mutant leads to a G1 arrest (Figure 7b ). Since HPV16 E7 associates with the hypophosphorylated form of pRb, it is fully competent to promote pRb degradation and S phase entry (Figure 7a,b) . In contrast, HPV16 E6 protein does not influence the intracellular levels of the DCDK-pRb mutant and, most importantly, is not able to override the G1 arrest imposed by the DCDK-pRb mutant. Thus, these data provide evidence that HPV16 E6 acts upstream of pRb, most likely by promoting its phosphorylation.
Discussion
In this study we identify a novel activity of E6 protein, which alleviates the G1 arrest imposed by antiproliferative signals, i.e. the absence of mitogenic factors and high levels of negative cell cycle regulators, p16
INK4a and p27 KIP1 . The fact that HPV16 E6 is able to stimulate the transcriptional activity of cyclins E and A promoters in serum deprived cells further confirms the HPV16 E6 activity in the deregulation of G1/S transition. This novel E6 property appears to be a property common in other HPV types. Indeed, E6 from the non-oncogenic cutaneous HPV1 displays a similar efficiency to HPV16 E6 in stimulating S phase progression. The findings indicate that this E6 activity is important for the viral life cycle and is not linked to the in vivo oncogenicity of HPV, since HPV1 has never been found to be associated with malignant lesions. Interestingly, it has been shown that HPV1 E6 is not able to promote p53 degradation (Elbel et al., 1997) . Thus, it is likely that this E6 activity is independent of p53 inactivation.
Overexpression of a pRb mutant (DCDK-pRb), in which all CDK-phosphorylation sites have been replaced by alanine residues, results in G1 arrest (Lukas et al., 1997) . We show that HPV16 E6 is not able to abrogate the DCDK-pRb-imposed cell cycle arrest, indicating that the ability of the viral protein to promote S phase entry is dependent on pRb phosphorylation.
We have observed that E7 has a higher activity than E6 in overcoming cell cycle arrest. This different efficiency of the viral proteins is most likely due to their different mechanisms in deregulating the G1/S transition. For instance, the better capability of HPV16 E7 in overriding p27 KIP1 -induced arrest can be explained by its dual activity to alter G1/S transition, first by neutralizing the pRb pathway (Martin et al., 1998; Zerfass et al., 1995) and second by inactivating p27 KIP1 via direct binding . HPV is totally dependent on the host machinery to replicate its own DNA. Since HPV DNA replication occurs in suprabasal cells of the epithelia, which are normally quiescent, the virus developed a mechanism to drive these cells into S phase and reactivate the host DNA replication machinery. Here we show that in addition to the well characterized E7 mechanism, E6 is also involved in this event. These findings provide a possible explanation as to why certain HPV types encoding an E7 that does not efficiently inactivate pRb, are still competent to induce cellular proliferation and to complete their life cycle in vivo. Future studies are required to elucidate the mechanism of E6 in the alteration of cell cycle control.
Materials and methods
Retroviral expression vectors
The retroviral vector pBabe-puro and pBabe-neo were previously described (Morgenstern and Land, 1990) . The pBabe-puro/p16
INK4a and p27 KIP1 constructs were provided by Dr Bruno Amati (DNAX Research Institute, Palo Alto, CA, USA). The DCDK-pRb mutant was provided by Dr Jiri Bartek (Danish Cancer Society, Division of Cancer Biology, Copenhagen, Denmark) and sub-cloned in pBabe-puro vector.
Cell culture and retroviral infections
NIH3T3 and BOSC23 cells were cultured in Dulbecco's modified Eagle's medium supplemented, respectively, with 10% calf serum or fetal calf serum. High-titer retroviral supernatants (410 6 i.u/ml) were generated by transient transfection of BOSC23 cells and used to infect NIH3T3 cells as described (Pear et al., 1993) . Five ml of supernatant of BOSC23 (45610 6 i.u.) were used to infect 5610 5 cells. Double infections were performed as previously described (Alevizopoulos et al., 1997; Giarre`et al., 2001; Serrano et al., 1997; Vlach et al., 1996) with some modifications. Briefly, after the first infection, NIH3T3 were selected in 1 mg/ml of G418 for 7 -8 days. After the second infection, NIH3T3 cells were cultured in a medium containing 0.5 mg/ml of G418 and 2.0 mg/ml of puromycin for 48 h. Typically, more than 90% of cells were successfully infected and survived the antibiotic selection. The times of selection for both antibiotics correspond to the period in which 100% of uninfected cells died. After the completion of the selection cells were maintained in the presence of the two antibiotics for the duration of each experiment. All cultures were processed for all analyses at 60 -70% confluency.
Transient transfection and determination of cyclins E and A promoter activity NIH3T3 cell were transfected with 3 mg of pBabe or pBabe-E6 vector together with 5 mg of a construct containing the luciferase reporter gene under the control of cyclins E or A Schulze et al., 1995) using the calciumphosphate precipitation. Sixteen hours post-transfection cells were cultured in medium containing 0.5% FCS. After 24 h the cells were lysed and luciferase activity was determined. Luciferase activity was normalized to b-galactosidase activity obtained from a co-transfected cytomegalovirus-driven bgalactosidase plasmid (0.5 mg).
Cell extract preparation
Total cellular extracts were prepared from NIH3T3 cells (10 cm plate, 80% confluence) by lysing the cells in 1 ml of lysing buffer (20 mM Tris/HCl pH8, 200 mM NaCl, 0.5% Nonidet P40, 1 mM EDTA, 10 mM NaF, 0.1 mM Na 3 VO 4 , 1 mM PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin) for 20 min at 48C. After centrifugation (12 000 g, 5 min) the supernatant was collected and used for immunoprecipitation or polyacrylamide gel electrophoresis.
Immunoprecipitation, immunoblot analysis and antibodies
The immunoprecipitation of CDK2 complexes was performed using 1 mg of NIH3T3 total protein extract and an anti CDK2 antibody (provided by Dr Michele Pagano, Department of Pathology, School of Medicine, New York University). For immunoblotting analysis, 100 mg of total cell extract was fractionated by electrophoresis on a polyacrylamide gel containing 0.1% SDS. Proteins were transferred onto a Polyscreen PVDF membrane (NEN Life Sciences) in a Transcriptional-Blot semidry electrophoretic transfer cell (Bio-Rad) (130 mA, 1 h 30 min) and the immuno blot analysis was performed as described in (Alunni-Fabbroni et al., 2000) . The following antibodies were used: anti b-tubulin (TUB2.1, Sigma, dilution 1 : 1000), anti p16
INK4a (kindly provided by Dr Gordon Peters, Imperial Cancer Research Fund, London, UK, dilution 1 : 10), anti p27 KIP1 (Transduction Laboratory, USA, dilution 1 : 1000), anti pRb (554136, PharMigen, USA).
Determination of Histone H1 kinase activity
For the kinase reactions, 20 ml of anti-CDK2 immunopellets were washed once in kinase buffer (50 mM Tris/HCl pH 7.5, 10 mM MgCl 2 1 mM DTT and 100 mM ATP) and resuspended in 20 ml of the same buffer. Five ml of the suspension was mixed with 5 mCi of [g-32 P]ATP and 1 mg of histone H1 and incubated for 15 min. The reaction was stopped by addition of 5 ml of SDS-sample buffer for polyacrylamide gel electrophoresis.
Determination of the proliferative state of the different cell populations Colony formation assay As cells were split for selection with puromycin after p16
INK4a or pBpuro infection, they were diluted 20, 200 or 2000 times and allowed to grow for 10 -15 days as described in Vlach et al. (1996) . After this period cells were washed in PBS and colonies fixed and stained on the plates with crystal violet in 20% methanol. For the quantification of size colony a direct correlation between intensity of the stained colony versus number of cell per colony was estimated by counting several randomly selected colonies. Finally the number of colony with different size was determinate in the entire plate.
FACS analysis
After retroviral infection, cells were selected for 48 h, harvested by trypsinization, washed with phsophate-buffered saline (PBS) and fixed in 80% methanol at 7208C for 30 min. 10 5 cells were washed in PBS, and re-suspended in 500 ml of PBS containing RNase A (0.1 mg/ml). After incubation (30 min at 378C), propidium iodide was added (5 ml of a 50 mg/ml solution). Analysis by flow cytometry was performed with a Becton Dickinson FACSort. Cell cycle profiles were determined by using the Modfit cell cycle analysis software package.
Statistical analysis
For the statistical comparison of proliferation in E6 expressing cells and controls of the experiments we tested the individual ratios versus a normalized value of 1. This was achieved through a one-sided paired t-test applied to the log values of the S phase percentages of E6 expressing cells and controls of the independent assays. For each experiment we calculated the respective P-value and a statistically significant result was stated if the P-value was less than 0.05.
